Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance

Cancer Res. 2008 Jan 15;68(2):605-14. doi: 10.1158/0008-5472.CAN-07-5472.

Abstract

Hypoxic and/or anoxic tumor cells can have increased rates of mutagenesis and altered DNA repair protein expression. Yet very little is known regarding the functional consequences of any hypoxia-induced changes in the expression of proteins involved in DNA double-strand break repair. We have developed a unique hypoxic model system using H1299 cells expressing an integrated direct repeat green fluorescent protein (DR-GFP) homologous recombination (HR) reporter system to study HR under prolonged chronic hypoxia (up to 72 h under 0.2% O(2)) without bias from altered proliferation, cell cycle checkpoint activation, or severe cell toxicity. We observed decreased expression of HR proteins due to a novel mechanism involving decreased HR protein synthesis. Error-free HR was suppressed 3-fold under 0.2% O(2) as measured by the DR-GFP reporter system. This decrease in functional HR resulted in increased sensitivity to the DNA cross-linking agents mitomycin C and cisplatin but not to the microtubule-interfering agent, paclitaxel. Chronically hypoxic H1299 cells that had decreased functional HR were relatively radiosensitive [oxygen enhancement ratio (OER), 1.37] when compared with acutely hypoxic or anoxic cells (OER, 1.96-2.61). Using CAPAN1 cells isogenic for BRCA2 and siRNA to RAD51, we confirmed that the hypoxia-induced radiosensitivity was due to decreased HR capacity. Persistent down-regulation of HR function by the tumor microenvironment could result in low-fidelity DNA repair and have significant implications for response to therapy and genetic instability in human cancers.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Hypoxia / physiology*
  • Cell Proliferation
  • Cell Survival
  • DNA Repair Enzymes / biosynthesis*
  • DNA Repair Enzymes / genetics
  • Drug Resistance, Neoplasm* / drug effects
  • Humans
  • Oxygen / pharmacology*
  • Rad51 Recombinase / biosynthesis
  • Rad51 Recombinase / metabolism
  • Radiation Tolerance* / drug effects
  • Recombination, Genetic* / drug effects
  • Recombination, Genetic* / physiology
  • Time Factors
  • Tumor Cells, Cultured

Substances

  • RAD51 protein, human
  • Rad51 Recombinase
  • DNA Repair Enzymes
  • Oxygen